N. Tang, Huan Bai, Xing Chen, J. Gong, Deng-ju Li, Ziyong Sun
Journal of thrombosis and haemostasis : JTH, 2020
A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy remains to be validated.
Cited by 800 publications.
Field of study: Medicine